The Rise of Senaglutide/Tirzepatide: A Sweet Opportunity for Weight Loss

Hey everyone — as director of the top medical weight loss clinic in Pierce County (yes, I'll say it :-), I keep an eye on the business pages too, and this one made me smile: The Hershey Company publicly acknowledged a "mild impact" on sales from the growing popularity of GLP-1 medications like Semaglutide and Tirzepatide.

Translation from corporate-speak: people on these medications are buying less candy, and the biggest candy company in America noticed.

Add it to the list. McDonald's stock downgraded over GLP-1 influence. Grocery bills down 9% in GLP-1 households (Cornell). Smaller clothing sizes flying off racks (WSJ). Snack aisles being reformulated (Axios). And now Hershey, quietly adjusting projections because millions of people don't reach for the chocolate like they used to.

Here's why I keep sharing these stories: they're the cultural proof of what we see clinically every day. When patients tell us "the food noise just... stopped," that's one person. When Hershey's quarterly earnings feel it, that's the same sentence multiplied by millions.

The food industry spent a century perfecting products designed to be irresistible. And for the first time, there's a counterweight — not a willpower seminar, but an actual biological answer to engineered craving.

The candy aisle will survive, I'm sure. But the balance of power just shifted, and it shifted toward you.

-Daryl

Book a FREE consult now <- Click There!

www.pnwmedicalgroup.com

Puyallup: 253-340-2270

Federal Way: 253-363-8877